ArticleFrontiers in pharmacology2024

Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC.

Xue Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.